No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Vulval Atrophy is a condition that affects the vulva, causing thinning and dryness of the skin. It is a common problem in post-menopausal women, and can cause discomfort and pain during sexual intercourse. Treatment for Vulval Atrophy includes topical creams and ointments, as well as systemic hormone therapy. Sexual and Reproductive Health Drugs are used to treat a variety of conditions related to sexual and reproductive health, including Vulval Atrophy. These drugs are designed to reduce symptoms and improve quality of life.
The Vulval Atrophy Drug market is a growing segment of the Sexual and Reproductive Health Drugs market. It is driven by an increasing awareness of the condition, as well as the availability of effective treatments. Companies in the market include Allergan, Pfizer, Merck, and Bayer. Show Less Read more
